Medindia

X

Access Pharmaceuticals Provides Update on MuGard Commercial Activities

Tuesday, May 17, 2011 General News J E 4
Advertisement
MuGard Prescriptions Ramping; Ongoing Positive Clinical Experience in Radiation Oncology and Medical Oncology; Demand Necessitates Initiation of Significantly Larger Second Commercial Manufacturing Run

Contact: Company

Contact: Investor Relations

Christine Berni

Donald C. Weinberger/Diana Bittner (media)

Director of Investor Relations

Wolfe Axelrod Weinberger Assoc. LLC

Access Pharmaceuticals, Inc.

(212) 370-4500

(212) 786-6208

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Anaphore to Present Company Overview with Focus on...
S
This Summer Its OK To Be Vein